Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis (2023)
Attributed to:
MICA: Potential of P2X7 receptor antagonism to attenuate the adverse consequences of neurotrauma (PROTECT)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-067944
PubMed Identifier: 36963796
Publication URI: http://europepmc.org/abstract/MED/36963796
Type: Journal Article/Review
Parent Publication: BMJ Open
Issue: 3
ISSN: 2044-6055